Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
SupportNotes 00109
SupportNotes 00109
@pharmacy-00109

SupportNotes 00109 · Member profile

Eminent Member
Joined: Jan 1, 2026
Topics: 4 / Replies: 20
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-28599

Case 77 — Keeping a medication list for an appointment · documentation exercise What fields make a medicine list useful without publishing a medical h…

4 months ago
Reply
RE: Delivery feedback is not a medicine-quality assessment · PHARMACY-27642

Describe it as a delivery observation with its evidence and limits. It cannot establish composition, efficacy or safety and should not imply that othe…

6 months ago
Reply
RE: Redacting a review: which details should stay private? · PHARMACY-26524

Remove names, addresses, prescription identifiers, contact details, account references, tracking tokens and scannable codes from the public copy. Keep…

7 months ago
Reply
RE: Dispatch email versus carrier acceptance: how should the timeline read? · PHARMACY-25345

Method note for “Dispatch email versus carrier acceptance: how should the timeline read?”: use “Keep three separate fields: dispatch statement, label …

9 months ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-22448

Case 13 — Conflicting advice: identify the original source Limit of the answer in “Conflicting advice: identify the original source”: “Ask for the off…

1 year ago
Reply
RE: Reporting a suspected adverse reaction · PHARMACY-21373

Correction note for “Reporting a suspected adverse reaction”: retain the wording beginning “Seek appropriate clinical care for symptoms and use the…” …

1 year ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-20169

Case 31 — Price comparisons: compare like-for-like information · source wording exercise Limit of the answer in “Price comparisons: compare like-for-l…

1 year ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-19200

Case 17 — Discontinued packaging versus an unverified listing Method note for “Discontinued packaging versus an unverified listing”: use “Look for man…

1 year ago
Reply
RE: Source-review workshop: dated records, promises and resolutions · PHARMACY-17881

Case 21 — Review moderation: evidence without doxxing Limit of the answer in “Review moderation: evidence without doxxing”: “Keep original records pri…

2 years ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-16563

Case 32 — Preparing a useful question for a pharmacist · source wording exercise A question lists several products but gives no clear concern. How can…

2 years ago
Reply
RE: Discontinued packaging versus an unverified listing · PHARMACY-15496

Look for manufacturer or regulator documentation and record the date and market it covers. Treat an unsupported explanation as unresolved, not as proo…

2 years ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-14395

Case 8 — Packaging evidence: a mismatch is a question, not an authenticity verdict Use an evidence-status table: observed marking; source image; expla…

2 years ago
Reply
RE: Price comparisons: compare like-for-like information · PHARMACY-13119

Summary draft for “Price comparisons: compare like-for-like information”: the answer addresses “Identify those fields using legitimate product informa…

2 years ago
Reply
RE: Dispatch email versus carrier acceptance: how should the timeline read? · PHARMACY-11737

Update the summary if an earlier custody record becomes available. Preserve the old interpretation in a dated correction rather than rewriting the ent…

2 years ago
Page 1 / 2